Pathological evaluation of the staging axillary lymph nodes for breast cancer: A national survey in the United Kingdom

Histopathology

Volumn 65, Issue 5, 2014, Pages 707-711

  Verma, Rashmi ^a   Sundara Rajan, Sreekumar ^b   Verghese, Eldo T ^b   Horgan, Kieran ^a   Hanby, Andrew M ^b   Lane, Sally ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Breast cancer; Sentinel lymph node biopsy; Survey

Indexed keywords

EOSIN; FORMALDEHYDE; HEMATOXYLIN; PARAFFIN;

ARTICLE; AXILLARY LYMPH NODE BIOPSY; BREAST CANCER; CANCER STAGING; CONTROLLED STUDY; CYTOLOGY; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; SENTINEL LYMPH NODE BIOPSY; STRUCTURED QUESTIONNAIRE; UNITED KINGDOM; AGED; AXILLA; BREAST NEOPLASMS; FEMALE; LYMPH NODE; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; QUESTIONNAIRE;

AGED; AXILLA; BREAST NEOPLASMS; FEMALE; FROZEN SECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PARAFFIN EMBEDDING; SENTINEL LYMPH NODE BIOPSY; SURVEYS AND QUESTIONNAIRES; UNITED KINGDOM;

EID: 84911364877     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12440     Document Type: Article

References (11)

1. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg. 1994; 220; 391-398; discussion 398-401.
2. Cote RJ, Peterson HF, Chaiwun B et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 1999; 354; 896-900.
3. Reed J, Rosman M, Verbanac KM, Mannie A, Cheng Z, Tafra L. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study. J. Am. Coll. Surg. 2009; 208; 333-340.
4. Association of Breast Surgery (ABS). Surgical guidelines for the management of breast cancer. Eur. J. Surg. Oncol. 2009; 35 (Suppl 1.); 1-22.
5. Straver ME, Meijnen P, van Tienhoven G et al. Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J. Clin. Oncol. 2010; 28; 731-737.
6. Giuliano AE, Hunt KK, Ballman KV et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011; 305; 569-575.
7. Ellis IO. Pathology reporting of breast disease. NHS Breast Screening Programme (NHSBSP) publication, NHS Cancer Screening Programmes and The Royal College of Pathologists. Publication No. 58, London, 2005
8. Fisher B, Bauer M, Margolese R et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N. Engl. J. Med. 1985; 312; 665-673.
9. Veronesi U, Saccozzi R, Del Vecchio M et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N. Engl. J. Med. 1981; 305; 6-11.
10. National Institute for Health and Care Excellence (NICE). Intraoperative tests (RD-100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer. NICE diagnostic guidance 8, 2013, ISBN 978-1-4731-0263-7, Manchester.
11. Tiernan JP, Verghese ET, Nair A et al. Systematic review and meta-analysis of cytokeratin 19-based one-step nucleic acid amplification versus histopathology for sentinel lymph node assessment in breast cancer. Br. J. Surg. 2014; 101; 298-306.